Suppr超能文献

哮喘生物标志物:改善哮喘管理的真正希望。

Biomarkers in asthma: a real hope to better manage asthma.

机构信息

Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine-CWRU, 9500 Euclid Avenue, NC22, Cleveland, OH 44195-0001, USA.

出版信息

Clin Chest Med. 2012 Sep;33(3):459-71. doi: 10.1016/j.ccm.2012.06.007. Epub 2012 Jul 25.

Abstract

Diagnosis and treatment of asthma are currently based on assessment of patient symptoms and physiologic tests of airway reactivity. Research over the past decade has identified an array of biochemical and cellular biomarkers, which reflect the heterogeneous and multiple mechanistic pathways that may lead to asthma. These mechanistic biomarkers offer hope for optimal design of therapies targeting the specific pathways that lead to inflammation. This article provides an overview of blood, urine, and airway biomarkers; summarizes the pathologic pathways that they signify; and begins to describe the utility of biomarkers in the future care of patients with asthma.

摘要

目前,哮喘的诊断和治疗是基于对患者症状和气道反应性的生理测试评估。过去十年的研究已经确定了一系列生化和细胞生物标志物,这些标志物反映了可能导致哮喘的异质性和多种机制途径。这些机制生物标志物为针对导致炎症的特定途径的治疗提供了最佳设计的希望。本文概述了血液、尿液和气道生物标志物;总结了它们所代表的病理途径;并开始描述生物标志物在未来哮喘患者护理中的应用。

相似文献

1
Biomarkers in asthma: a real hope to better manage asthma.哮喘生物标志物:改善哮喘管理的真正希望。
Clin Chest Med. 2012 Sep;33(3):459-71. doi: 10.1016/j.ccm.2012.06.007. Epub 2012 Jul 25.
6
Applying personalized medicine to adult severe asthma.将个体化医学应用于成人严重哮喘。
Allergy Asthma Proc. 2021 Jan 1;42(1):e8-e16. doi: 10.2500/aap.2021.42.200100.
8
How to diagnose and phenotype asthma.如何诊断和表型哮喘。
Clin Chest Med. 2012 Sep;33(3):445-57. doi: 10.1016/j.ccm.2012.05.003. Epub 2012 Jul 7.
9
Biomarkers of inflammation in asthma: a clinical perspective.哮喘炎症的生物标志物:临床视角。
Semin Respir Crit Care Med. 2012 Dec;33(6):620-9. doi: 10.1055/s-0032-1326960. Epub 2012 Oct 9.

引用本文的文献

1
Effects of Family-Supported Healthcare on Children with Asthma.家庭支持式医疗对哮喘儿童的影响。
Ther Clin Risk Manag. 2024 Jul 15;20:427-436. doi: 10.2147/TCRM.S464826. eCollection 2024.
2
GEMA 5.3. Spanish Guideline on the Management of Asthma.GEMA 5.3. 《西班牙哮喘管理指南》。
Open Respir Arch. 2023 Sep 19;5(4):100277. doi: 10.1016/j.opresp.2023.100277. eCollection 2023 Oct-Dec.
6
Metabolomic Endotype of Asthma.哮喘的代谢组学内型
J Immunol. 2015 Jul 15;195(2):643-50. doi: 10.4049/jimmunol.1500736. Epub 2015 Jun 5.

本文引用的文献

1
The pharmacogenetics and pharmacogenomics of asthma therapy.哮喘治疗的药物遗传学和药物基因组学。
Pharmacogenomics J. 2011 Dec;11(6):383-92. doi: 10.1038/tpj.2011.46. Epub 2011 Oct 11.
2
S-nitrosoglutathione reductase in human lung cancer.人肺癌中的 S-亚硝基谷胱甘肽还原酶。
Am J Respir Cell Mol Biol. 2012 Jan;46(1):63-70. doi: 10.1165/rcmb.2011-0147OC.
3
Lebrikizumab treatment in adults with asthma.来氟米特治疗成人哮喘。
N Engl J Med. 2011 Sep 22;365(12):1088-98. doi: 10.1056/NEJMoa1106469. Epub 2011 Aug 3.
4
The biochemistry of asthma.哮喘的生物化学
Biochim Biophys Acta. 2011 Nov;1810(11):1017-24. doi: 10.1016/j.bbagen.2011.06.008. Epub 2011 Jun 22.
5
Obesity and asthma: an association modified by age of asthma onset.肥胖与哮喘:与哮喘发病年龄相关的关联。
J Allergy Clin Immunol. 2011 Jun;127(6):1486-93.e2. doi: 10.1016/j.jaci.2011.03.036.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验